Decillion Finance Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 6, 2025, 8:28 am

Quick Insight

Decillion Finance Ltd, a Non-Banking Financial Company, is currently trading at a price of 49.0 with a market capitalization of 17.2 Cr. The high P/E ratio of 245 indicates that the stock may be overvalued relative to its earnings. However, the company's Return on Equity (ROE) of 0.56% and Return on Capital Employed (ROCE) of 1.01% are relatively low, suggesting inefficiency in capital utilization. With an Operating Profit Margin (OPM) of 59.26%, Decillion Finance is generating healthy profits. The low Price-to-Book Value (P/BV) ratio of 0.36x may present a value investment opportunity, but investors should be cautious due to the lack of clarity on Promoters, FIIs, DIIs, and other key stakeholders. In conclusion, potential investors should conduct further due diligence to fully understand the company's financial health and prospects.

Competitors of Decillion Finance Ltd

All Competitor Stocks of Decillion Finance Ltd

Quarterly Result

Last Updated: August 19, 2025, 8:20 pm

Below is a detailed analysis of the quarterly data for Decillion Finance Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 0.27 Cr.. The value appears strong and on an upward trend. It has increased from 0.26 Cr. (Mar 2025) to 0.27 Cr., marking an increase of 0.01 Cr..
• For Expenses, as of Jun 2025, the value is 0.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Mar 2025) to 0.11 Cr., marking an increase of 0.06 Cr..
• For Operating Profit, as of Jun 2025, the value is 0.16 Cr.. The value appears to be declining and may need further review. It has decreased from 0.21 Cr. (Mar 2025) to 0.16 Cr., marking a decrease of 0.05 Cr..
• For OPM %, as of Jun 2025, the value is 59.26%. The value appears to be declining and may need further review. It has decreased from 80.77% (Mar 2025) to 59.26%, marking a decrease of 21.51%.
• For Other Income, as of Jun 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
• For Interest, as of Jun 2025, the value is 0.01 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.01 Cr..
• For Depreciation, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 0.15 Cr.. The value appears to be declining and may need further review. It has decreased from 0.22 Cr. (Mar 2025) to 0.15 Cr., marking a decrease of 0.07 Cr..
• For Tax %, as of Jun 2025, the value is 26.67%. The value appears to be increasing, which may not be favorable. It has increased from 13.64% (Mar 2025) to 26.67%, marking an increase of 13.03%.
• For Net Profit, as of Jun 2025, the value is 0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 0.20 Cr. (Mar 2025) to 0.11 Cr., marking a decrease of 0.09 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.31. The value appears to be declining and may need further review. It has decreased from 0.57 (Mar 2025) to 0.31, marking a decrease of 0.26.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 1:57 pm

Growth

Last Updated: September 5, 2025, 3:11 pm

Balance Sheet

Last Updated: July 25, 2025, 1:28 pm

Below is a detailed analysis of the balance sheet data for Decillion Finance Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 3.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 3.50 Cr..
• For Reserves, as of Mar 2025, the value is 8.94 Cr.. The value appears strong and on an upward trend. It has increased from 8.87 Cr. (Mar 2024) to 8.94 Cr., marking an increase of 0.07 Cr..
• For Borrowings, as of Mar 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.83 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 0.83 Cr..
• For Other Liabilities, as of Mar 2025, the value is 0.87 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.51 Cr. (Mar 2024) to 0.87 Cr., marking an increase of 0.36 Cr..
• For Total Liabilities, as of Mar 2025, the value is 13.31 Cr.. The value appears to be improving (decreasing). It has decreased from 13.71 Cr. (Mar 2024) to 13.31 Cr., marking a decrease of 0.40 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.40 Cr.. The value appears strong and on an upward trend. It has increased from 0.39 Cr. (Mar 2024) to 0.40 Cr., marking an increase of 0.01 Cr..
• For Other Assets, as of Mar 2025, the value is 12.91 Cr.. The value appears to be declining and may need further review. It has decreased from 13.32 Cr. (Mar 2024) to 12.91 Cr., marking a decrease of 0.41 Cr..
• For Total Assets, as of Mar 2025, the value is 13.31 Cr.. The value appears to be declining and may need further review. It has decreased from 13.71 Cr. (Mar 2024) to 13.31 Cr., marking a decrease of 0.40 Cr..

Notably, the Reserves (8.94 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

No data available for the No. of Shareholders chart.

Key Financial Ratios

After reviewing the key financial ratios for Decillion Finance Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 20, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 5. It has decreased from 0.41 (Mar 19) to -0.16, marking a decrease of 0.57.
• For Diluted EPS (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 5. It has decreased from 0.41 (Mar 19) to -0.16, marking a decrease of 0.57.
• For Cash EPS (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 3. It has decreased from 0.33 (Mar 19) to -0.16, marking a decrease of 0.49.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 32.08. It has decreased from 33.69 (Mar 19) to 32.08, marking a decrease of 1.61.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 32.08. It has decreased from 33.69 (Mar 19) to 32.08, marking a decrease of 1.61.
• For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 1.88. It has decreased from 4.77 (Mar 19) to 1.88, marking a decrease of 2.89.
• For PBDIT / Share (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 2. It has decreased from 0.63 (Mar 19) to -0.16, marking a decrease of 0.79.
• For PBIT / Share (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 0. It has decreased from 0.62 (Mar 19) to -0.16, marking a decrease of 0.78.
• For PBT / Share (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 0. It has decreased from 0.45 (Mar 19) to -0.16, marking a decrease of 0.61.
• For Net Profit / Share (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 2. It has decreased from 0.33 (Mar 19) to -0.16, marking a decrease of 0.49.
• For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is -0.16. This value is below the healthy minimum of 2. It has decreased from 0.40 (Mar 19) to -0.16, marking a decrease of 0.56.
• For PBDIT Margin (%), as of Mar 20, the value is -8.79. This value is below the healthy minimum of 10. It has decreased from 13.21 (Mar 19) to -8.79, marking a decrease of 22.00.
• For PBIT Margin (%), as of Mar 20, the value is -8.79. This value is below the healthy minimum of 10. It has decreased from 13.20 (Mar 19) to -8.79, marking a decrease of 21.99.
• For PBT Margin (%), as of Mar 20, the value is -8.79. This value is below the healthy minimum of 10. It has decreased from 9.54 (Mar 19) to -8.79, marking a decrease of 18.33.
• For Net Profit Margin (%), as of Mar 20, the value is -8.72. This value is below the healthy minimum of 5. It has decreased from 7.01 (Mar 19) to -8.72, marking a decrease of 15.73.
• For NP After MI And SOA Margin (%), as of Mar 20, the value is -8.72. This value is below the healthy minimum of 8. It has decreased from 8.51 (Mar 19) to -8.72, marking a decrease of 17.23.
• For Return on Networth / Equity (%), as of Mar 20, the value is -0.51. This value is below the healthy minimum of 15. It has decreased from 1.24 (Mar 19) to -0.51, marking a decrease of 1.75.
• For Return on Capital Employeed (%), as of Mar 20, the value is -0.51. This value is below the healthy minimum of 10. It has decreased from 1.81 (Mar 19) to -0.51, marking a decrease of 2.32.
• For Return On Assets (%), as of Mar 20, the value is -0.51. This value is below the healthy minimum of 5. It has decreased from 1.16 (Mar 19) to -0.51, marking a decrease of 1.67.
• For Long Term Debt / Equity (X), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.02 (Mar 19) to 0.00, marking a decrease of 0.02.
• For Total Debt / Equity (X), as of Mar 20, the value is 0.00. This value is within the healthy range. It has decreased from 0.02 (Mar 19) to 0.00, marking a decrease of 0.02.
• For Asset Turnover Ratio (%), as of Mar 20, the value is 0.05. It has decreased from 0.13 (Mar 19) to 0.05, marking a decrease of 0.08.
• For Current Ratio (X), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 1.5. It has decreased from 209.03 (Mar 19) to 0.00, marking a decrease of 209.03.
• For Quick Ratio (X), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 177.87 (Mar 19) to 0.00, marking a decrease of 177.87.
• For Interest Coverage Ratio (X), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 3. It has decreased from 3.60 (Mar 19) to 0.00, marking a decrease of 3.60.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 0.00. This value is below the healthy minimum of 3. It has decreased from 2.91 (Mar 19) to 0.00, marking a decrease of 2.91.
• For Enterprise Value (Cr.), as of Mar 20, the value is 4.03. It has decreased from 4.70 (Mar 19) to 4.03, marking a decrease of 0.67.
• For EV / Net Operating Revenue (X), as of Mar 20, the value is 6.11. This value exceeds the healthy maximum of 3. It has increased from 2.82 (Mar 19) to 6.11, marking an increase of 3.29.
• For EV / EBITDA (X), as of Mar 20, the value is -69.46. This value is below the healthy minimum of 5. It has decreased from 21.33 (Mar 19) to -69.46, marking a decrease of 90.79.
• For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 6.13. This value exceeds the healthy maximum of 3. It has increased from 2.42 (Mar 19) to 6.13, marking an increase of 3.71.
• For Price / BV (X), as of Mar 20, the value is 0.36. This value is below the healthy minimum of 1. It has increased from 0.35 (Mar 19) to 0.36, marking an increase of 0.01.
• For Price / Net Operating Revenue (X), as of Mar 20, the value is 6.13. This value exceeds the healthy maximum of 3. It has increased from 2.42 (Mar 19) to 6.13, marking an increase of 3.71.
• For EarningsYield, as of Mar 20, the value is -0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 19) to -0.01, marking a decrease of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness